NCT06801522 Adrenaline Nasal Pack vs Xylometazoline Nasal Drops During Nasotracheal Intubation
| NCT ID | NCT06801522 |
| Status | Recruiting |
| Phase | Phase 2, Phase 3 |
| Sponsor | Shaheed Mohtarma Benazir Bhutto Institue of Trauma |
| Condition | Nasal Bleeding |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-12-01 |
| Primary Completion | 2025-03 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The goal of this trial is to compare efficacy of xylometazoline nasal drops and adrenaline nasal pack in participants undergoing elective oromaxillofacial surgeries. The main question aim to answer is xylometazoline nasal drops better than adrenaline nasal packing in terms of nasal bleeding during nasotracheal intubation. Researchers are comparing 2 groups of participants. Participants in group Xylometazoline are receiving 0.1% xylometaxoline nasal drops. Participants in group Adrenaline are receiving adrenaline nasal packing.
Eligibility Criteria
Inclusion Criteria: * ASA 1 and 2 * Age group between 18-60 years * Mallampati score 1 and 2 * Either gender * Participants who undergo elective oromaxillofacial surgery Exclusion Criteria: * Lack of consent * Participants with anticipated difficult airway * Participants receiving anticoagulant therapy * History of nasal abnormality (nasal surgery, trauma, polyp, obstruction) * History of repeated epistaxis * History of uncontrolled hypertension, diabetes, pregnancy, and any other cardiac or cerebral events.